| |
|
|
| |
Injectable Drug Delivery
Drugs, Devices, Targets, Therapeutics and
Forecasts
|
Publication: January 2012
Product Code: KDJ558F
|
The past decade has seen a dramatic shift in terms of the
types of approved injectable drugs, the diseases they
target, and the devices used to deliver them. This shift has
fostered change on several levels of the healthcare sector.
The injectable drug segment has seen a marked increase in
the level of drug/device integration, as prefilled syringes
and specialized injection devices proliferate in response to
safety and economic challenges posed by recombinant protein
drugs, while administration of injectables has moved
increasingly from practitioner offices and healthcare
facilities to patient homes. This report examines the key
therapeutic, product, market and regulatory factors for
injectable drugs across ten major disease and therapeutic
classes, providing essential insight and forecasts into the
implications of this evolving landscape. |
|
Highlights |
· Analyzes and evaluates
the shifting landscape for injectable drug delivery and
assesses the market impact of new and emerging
injectable drug products by therapeutic indication
· Analyzes syringe and
injector device designs, feature/functionality, product
branding, competing technologies and market development
issues
· Provides detailed
descriptions of key injectable drug therapeutic market
segments, market demographics, and business strategies
· Forecasts Injectable
drug product demand by indication and therapy to 2016
· Profiles leading injection
device companies, their product development
activities, business strategies, and corporate
alliances and affiliations
|
|
Summary of Contents |
Executive Summary
Injectable Drugs – The
Market Opportunity The Evolving Drug
Therapeutics Landscape Injectable Drug Demand
Drivers Diseases and Indications Patient
Demographics Developing Economies Market
Factors Managed Care and Healthcare Costs
Regulations and Regulatory Sentiment Technology
Drivers Drug Stability Device Design &
Technology Patient and Care-giver Sentiment
Self-Administration and Patient-friendly Features
Commercial Injection Devices Syringes
Traditional Disposables Prefilled Syringes
Glass Plastic Prefillable Safety Syringes
Autoinjectors Safety Syringes Pen Injectors
Needle-free Injectors Novel Injection Devices
Injectable Drug Therapeutics – Technology
Factors Formulation Factors Biological Drug
Stability Sustained Release Formulations
Lyophilization and Reconstitution Growth of
Prefilled Syringes Partnerships and Alliances
PFS Manufacturing Fill-and-Finish Operations
Device Selection Factors Drug-Device
Compatibility Luer vs Fixed Needle Customized
injection Devices
Injectable Drug
Therapeutics – Market Factors Regulatory Factors
and Issues FDA Regulations FDA Guidance
Regulating Combination Products Sharps
Legislations Growth and Diversity of Safety
Syringes Sharps Disposal Clinical Trial
Factors Managed Care and Healthcare Economics
Injectable Drug Therapeutics – Segment
Assessments and Forecasts Anemia
Anticoagulants Growth Hormone Deficiency
Hepatitis Inflammatory Autoimmune Diseases
Osteoporosis Multiple Sclerosis Reproductive
Medicine
Profiles of Market Participants
|
|
|
|
|